Reformulary Group announces Cannabis Standard, Canada’s first evidence-based medical cannabis formulary

X

Amber Mac's Dx3 2016 Tech Spotlight Interview with CEO Helen Stevenson of Reformulary Group

Amber Mac's Dx3 2016 Tech Spotlight Interview with CEO Helen Stevenson of Reformulary Group